Intuitive Sale Purchase Of Stock vs Begin Period Cash Flow Analysis
ISRG Stock | USD 538.55 3.55 0.65% |
Intuitive Surgical financial indicator trend analysis is infinitely more than just investigating Intuitive Surgical recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Intuitive Surgical is a good investment. Please check the relationship between Intuitive Surgical Sale Purchase Of Stock and its Begin Period Cash Flow accounts. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Intuitive Surgical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. For more detail on how to invest in Intuitive Stock please use our How to Invest in Intuitive Surgical guide.
Sale Purchase Of Stock vs Begin Period Cash Flow
Sale Purchase Of Stock vs Begin Period Cash Flow Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Intuitive Surgical Sale Purchase Of Stock account and Begin Period Cash Flow. At this time, the significance of the direction appears to have significant contrarian relationship.
The correlation between Intuitive Surgical's Sale Purchase Of Stock and Begin Period Cash Flow is -0.24. Overlapping area represents the amount of variation of Sale Purchase Of Stock that can explain the historical movement of Begin Period Cash Flow in the same time period over historical financial statements of Intuitive Surgical, assuming nothing else is changed. The correlation between historical values of Intuitive Surgical's Sale Purchase Of Stock and Begin Period Cash Flow is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Sale Purchase Of Stock of Intuitive Surgical are associated (or correlated) with its Begin Period Cash Flow. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Begin Period Cash Flow has no effect on the direction of Sale Purchase Of Stock i.e., Intuitive Surgical's Sale Purchase Of Stock and Begin Period Cash Flow go up and down completely randomly.
Correlation Coefficient | -0.24 |
Relationship Direction | Negative |
Relationship Strength | Insignificant |
Sale Purchase Of Stock
Begin Period Cash Flow
The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.Most indicators from Intuitive Surgical's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Intuitive Surgical current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Intuitive Surgical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. For more detail on how to invest in Intuitive Stock please use our How to Invest in Intuitive Surgical guide.The Intuitive Surgical's current Selling General Administrative is estimated to increase to about 2.1 B. The Intuitive Surgical's current Tax Provision is estimated to increase to about 162.9 M
2021 | 2022 | 2023 | 2024 (projected) | Depreciation And Amortization | 310.2M | 380.4M | 421.8M | 442.9M | Income Tax Expense | 162.2M | 262.4M | 141.6M | 137.0M |
Intuitive Surgical fundamental ratios Correlations
Click cells to compare fundamentals
Intuitive Surgical Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Intuitive Surgical fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 9.7B | 11.2B | 13.6B | 13.0B | 15.4B | 16.2B | |
Total Stockholder Equity | 8.3B | 9.8B | 12.0B | 11.1B | 13.3B | 14.0B | |
Net Debt | (1.1B) | (1.5B) | (1.2B) | (1.5B) | (2.7B) | (2.5B) | |
Retained Earnings | 2.5B | 3.3B | 4.8B | 3.5B | 4.7B | 5.0B | |
Common Stock Shares Outstanding | 358.5M | 360.9M | 365.8M | 362M | 357.4M | 333.9M | |
Liabilities And Stockholders Equity | 9.7B | 11.2B | 13.6B | 13.0B | 15.4B | 16.2B | |
Non Current Liabilities Total | 159.7M | 139M | 224.1M | 439.3M | 385.5M | 404.8M | |
Other Stockholder Equity | 5.8B | 6.4B | 7.2B | 7.7B | 8.6B | 9.0B | |
Total Liab | 1.4B | 1.4B | 1.6B | 1.9B | 2.0B | 2.1B | |
Other Current Liab | 568.9M | 486.1M | 576.9M | 781.7M | 912.5M | 958.1M | |
Total Current Liabilities | 1.4B | 1.4B | 1.6B | 1.9B | 1.7B | 1.7B | |
Property Plant And Equipment Net | 1.3B | 1.6B | 1.9B | 2.4B | 3.5B | 3.7B | |
Accounts Payable | 1.1B | 81.6M | 121.2M | 147M | 188.7M | 101.8M | |
Cash | 1.2B | 1.6B | 1.3B | 1.6B | 2.8B | 1.6B | |
Non Current Assets Total | 2.2B | 3.1B | 3.6B | 4.4B | 7.6B | 7.9B | |
Cash And Short Term Investments | 5.8B | 6.9B | 8.6B | 6.7B | 5.2B | 2.8B | |
Net Receivables | 645.2M | 645.5M | 893M | 1.1B | 1.3B | 1.3B | |
Short Term Investments | 2.1B | 3.5B | 2.9B | 2.5B | 2.5B | 2.6B | |
Inventory | 595.5M | 601.5M | 587.1M | 893.2M | 1.2B | 1.3B | |
Other Current Assets | 200.2M | 393.8M | 133.9M | 168.6M | 176.7M | 185.5M | |
Total Current Assets | 7.5B | 8.1B | 10.0B | 8.6B | 7.9B | 8.3B | |
Accumulated Other Comprehensive Income | 12.4M | 24.9M | (24.2M) | (162.5M) | (12.2M) | (12.8M) | |
Short Term Debt | 568.9M | 21.9M | 20.4M | 24.2M | 25.3M | 24.0M | |
Non Currrent Assets Other | (2.4B) | (986.6M) | (3.5B) | (1.6B) | 597.6M | 627.5M | |
Property Plant And Equipment Gross | 1.3B | 1.6B | 2.8B | 3.6B | 5.1B | 5.4B | |
Intangible Assets | 112.1M | 77.4M | 70.5M | 49.8M | 39.1M | 69.4M | |
Property Plant Equipment | 1.3B | 1.6B | 1.9B | 2.4B | 2.7B | 2.9B | |
Current Deferred Revenue | 365.2M | 382.4M | 414M | 438.3M | 446.1M | 468.4M | |
Other Liab | 349.6M | 386.6M | 414M | 369.7M | 425.2M | 446.4M | |
Other Assets | 680.5M | 2.1B | 13.6B | 1.2B | 1.4B | 1.1B | |
Good Will | 307.2M | 336.7M | 343.6M | 348.5M | 348.7M | 214.6M | |
Net Tangible Assets | 7.5B | 8.9B | 11.6B | 10.0B | 11.5B | 5.9B | |
Noncontrolling Interest In Consolidated Entity | 20.9M | 27.6M | 50.4M | 70.7M | 81.3M | 85.4M | |
Retained Earnings Total Equity | 2.5B | 3.3B | 4.8B | 3.5B | 4.0B | 4.2B | |
Capital Surpluse | 5.8B | 6.4B | 7.2B | 7.7B | 8.9B | 4.6B | |
Deferred Long Term Liab | 51.5M | 53.1M | 71.8M | 72.3M | 83.1M | 87.3M | |
Long Term Investments | 2.6B | 1.8B | 4.4B | 2.6B | 2.1B | 2.1B |
Currently Active Assets on Macroaxis
When determining whether Intuitive Surgical is a strong investment it is important to analyze Intuitive Surgical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Intuitive Surgical's future performance. For an informed investment choice regarding Intuitive Stock, refer to the following important reports:Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Intuitive Surgical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. For more detail on how to invest in Intuitive Stock please use our How to Invest in Intuitive Surgical guide.You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Intuitive Surgical. If investors know Intuitive will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Intuitive Surgical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.345 | Earnings Share 6.19 | Revenue Per Share 22.22 | Quarterly Revenue Growth 0.169 | Return On Assets 0.0795 |
The market value of Intuitive Surgical is measured differently than its book value, which is the value of Intuitive that is recorded on the company's balance sheet. Investors also form their own opinion of Intuitive Surgical's value that differs from its market value or its book value, called intrinsic value, which is Intuitive Surgical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Intuitive Surgical's market value can be influenced by many factors that don't directly affect Intuitive Surgical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Intuitive Surgical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Intuitive Surgical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Intuitive Surgical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.